Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Depression after myocardial infarction.

R C Ziegelstein1

  • 1Department of Medicine, Division of Cardiology, Johns Hopkins Bayview Medical Center, Johns Hopkins University School of Medicine, 4940 Eastern Avenue, Baltimore 21224-2780, USA.

Cardiology in Review
|February 15, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Platelet function in patients with major depression.

Internal medicine journal·2009
Same author

Post-myocardial infarction depression.

Evidence report/technology assessment (Summary)·2005
Same author

Expression of polycystin-1 enhances endoplasmic reticulum calcium uptake and decreases capacitative calcium entry in ATP-stimulated MDCK cells.

American journal of physiology. Renal physiology·2005
Same author

Depression in patients recovering from a myocardial infarction.

JAMA·2001
Same author

Even minimal symptoms of depression increase mortality risk after acute myocardial infarction.

The American journal of cardiology·2001
Same author

Determinants of shear stress-stimulated endothelial nitric oxide production assessed in real-time by 4,5-diaminofluorescein fluorescence.

Biochemical and biophysical research communications·2001
Same journal

Cardiotoxicity of Antibody-Drug Conjugates in HER2-Positive Cancer: Beyond Left Ventricular Ejection Fraction Decline.

Cardiology in review·2026
Same journal

Celiac Disease and Cardiovascular Disease: Epidemiology, Mechanisms, and Clinical Challenges.

Cardiology in review·2026
Same journal

Valve-Specific Comparative Effectiveness of Direct Oral Anticoagulants Versus Vitamin K Antagonists After Surgical Valve Procedures in Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Cardiology in review·2026
Same journal

Growing Heart Valves in Congenital Cardiac Surgery: Mechanisms and Considerations for Tissue-Engineered Heart Valves, Noncryopreserved Homografts, and Partial Heart Transplantation.

Cardiology in review·2026
Same journal

Implementation Gaps and Limitations of Statin Therapy in Young Adults: Bridging Guideline Recommendations and Real-World Practice.

Cardiology in review·2026
Same journal

Cardiovascular Manifestations of Epilepsy.

Cardiology in review·2026
See all related articles

Depression significantly increases heart attack (myocardial infarction) risks. Treating mood disorders after a heart attack may reduce mortality, but more research is needed to confirm benefits.

Area of Science:

  • Cardiology
  • Psychiatry
  • Psychosomatic Medicine

Background:

  • Depression is a significant independent risk factor for adverse outcomes following myocardial infarction (MI).
  • Nearly half of MI survivors experience some form of depression, with major depression affecting about 20% of individuals.
  • The precise mechanisms linking depression to poorer cardiac outcomes remain incompletely understood.

Purpose of the Study:

  • To review the relationship between depression and post-myocardial infarction morbidity and mortality.
  • To explore potential pathophysiologic mechanisms underlying this association.
  • To discuss uncertainties regarding optimal depression treatment and its impact on mortality in MI patients.

Main Methods:

  • Literature review and synthesis of existing research on depression after myocardial infarction.

Related Experiment Videos

  • Analysis of potential biological and behavioral pathways connecting mood disorders to cardiac events.
  • Discussion of current knowledge gaps in treatment efficacy and mortality reduction.

    • Main Results:

    • Depression independently elevates the risk of morbidity and mortality after MI, irrespective of traditional cardiac risk factors.
    • Potential contributing factors include reduced social support, poor treatment adherence, autonomic dysfunction, and immune system activation.
    • Optimal treatment strategies and their effect on mortality risk in this population are not yet established.

    Conclusions:

    • Identifying depression as a risk factor warrants routine psychological screening for MI patients.
    • Further research is crucial to determine if treating depression in post-MI individuals can reduce associated mortality.
    • Establishing the efficacy of psychosocial interventions and antidepressant therapy is a key area for ongoing studies.